Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 3];7(2):s124. Available from: https://skin.dermsquared.com/skin/article/view/1952